Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-005745

EVP, Research & CSO sold 31,300 shares at $48.17 ($1,507,806)

  • EVP, Research & CSO acquired 31,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-26 Option exercise +31,300 $1.53 $47,889 64,500 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-01-26 Sale −31,300 $48.17 $1,507,806 33,200 D: show line 2 in the form
Open-market sales · 31,300 sh · avg $48.17 · $1,507,806

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-01-26 Option exercise · Stock Option (Right to Buy) −31,300 380,155 D: show line 3 in the form
Loading xslF345X03/doc4.xml…